Insider · CIK 0001229055
Frederick Pierce II
Files at DCOY (Salarius Pharmaceuticals, Inc.). First filing -, latest -.
Frederick Pierce II files SEC Form 4 as CEO at DCOY (Salarius Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Frederick Pierce II has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | DCOY Salarius Pharmaceuticals, Inc. | AGrant or award Common Stock | +33,455 | $0.00 | $0 | 34,844 | 41 d ago |
Questions about Frederick Pierce II
Answered from the filings on this page, as of the latest one.
Is Frederick Pierce II buying or selling?
Frederick Pierce II has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Frederick Pierce II's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Frederick Pierce II has 0.
Where does Frederick Pierce II file Form 4?
Frederick Pierce II has filed Form 4 at DCOY (Salarius Pharmaceuticals, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.